Loading...
XNAS
RKDA
Market cap4mUSD
Dec 05, Last price  
3.64USD
1D
-0.27%
1Q
15.56%
Jan 2017
-99.51%
IPO
-99.94%
Name

Arcadia Biosciences Inc

Chart & Performance

D1W1MN
XNAS:RKDA chart
P/E
P/S
0.99
EPS
Div Yield, %
Shrs. gr., 5y
53.67%
Rev. gr., 5y
33.97%
Revenues
5m
-5.35%
7,010,0006,478,0006,982,0005,414,0003,188,0004,026,0001,464,0001,169,0008,034,0006,780,0009,956,0005,330,0005,045,000
Net income
-7m
L-49.66%
-12,370,000-13,195,000-18,339,000-17,956,000-19,624,000-15,707,000-13,480,000-28,873,000-6,026,000-16,134,000-15,612,000-13,981,000-7,038,000
CFO
-10m
L-37.05%
-9,588,000-9,745,000-14,787,000-15,109,000-17,055,000-13,965,000-13,631,000-17,198,000-30,218,000-25,868,000-13,977,000-15,294,000-9,627,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Arcadia Biosciences, Inc. produces and markets plant-based health and wellness products in the United States. It engages in developing crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications. The company was incorporated in 2002 and is headquartered in Davis, California.
IPO date
May 15, 2015
Employees
30
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT